Loss of muscle mass and bone density are two critical issues of aging that disproportionately affect women. Resistance ...

Published in The New England Journal of Medicine, the case was originally reported in 1996 and has recently resurfaced ...

For early postmenopausal women, zoledronate administered at baseline and 5 years is effective for preventing morphometric ...

Adding a monoclonal antibody cocktail to the standard treatment for inoperable liver cancer nearly doubled the amount of time ...

Recent studies highlight breakthroughs in medical treatments. A novel monoclonal antibody cocktail has shown promise in ...

Designed to bridge the disconnect between acute fracture care and long-term osteoporosis management, Fracture Liaison Services (FLS) are specialised programs that ensure patients who experience a ...

The Faculty of Medicine of Utrecht University and the UMC Utrecht work together in the field of medical education, biomedical education and research. The various tasks are carried out in the UMC ...

15 in the New England Journal of Medicine. They also had a lower risk ... but it hadn't been tested to see if early treatment could prevent bone loss in early postmenstrual women, even those ...

cheap IV infusions of a bone-strengthening drug. Women 50 to 60 who got two IV infusions of zoledronate (Reclast) within five years had a 44% lower risk of spinal fractures, compared to women who ...

Karl-Anthony Towns has a bone chip in his right thumb in addition to a sprain, and is considered day-to-day going forward, ESPN’s Cassidy Hubbarth confirmed during Wednesday’s ESPN telecast of ...

A ground-breaking New Zealand trial has discovered a cheap treatment given only once every five to 10 years can prevent devastating bone fractures in women who have gone through menopause.